Policy | December 03, 2021
Over one lakh SARS-CoV-2 genomes sequenced till November
Union Minister Dr Jitendra Singh said a large number of Covid-19 bio-repositories and samples were made available to academia and industry
Union Minister Dr Jitendra Singh said a large number of Covid-19 bio-repositories and samples were made available to academia and industry
A single-cell analysis solution that revolutionizes efficiency in drug discovery research by automating the collection of specific cells and intracellular components
Preclinical data demonstrate sotrovimab, authorised in multiple countries around the world, retains activity against all tested variants of concern, including key mutations of Omicron
ALASTIN’s patented, differentiated technology and products are highly synergistic with Galderma’s premium portfolio
The campaign aims to increase awareness about Tuberculosis as a curable disease and promote early diagnosis.
Market demand for significant volumes and quality of biopharma products would drive continuous manufacturing technologies
Owkin builds best-in-class predictive biomedical AI models and robust data sets
The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022
The company is marketing the kit under the brand name CoviFind and it can detect the infection in 15 minutes
The Indian medical devices industry has been in focus since the pandemic. From US $ 11 billion in 2020 it is expected to touch US $ 50 billion by 2025. Mehernosh Daruwalla, Founder and MD, Lotus Surgicals shares a perspective with Thomas C Thottathil on the opportunities in this sector
Subscribe To Our Newsletter & Stay Updated
